UAE’s Burjeel Medical City Successfully Carries Out Its First Kidney Transplant
15.9.2022 12:05:00 EEST | Business Wire | Press release
Providing an option for local and international patients to undergo kidney transplantation in private hospitals in the UAE’s Abu Dhabi, Burjeel Medical City (BMC) has started performing kidney transplantations. The first such transplantation was successfully performed on a patient from Kazakhstan at BMC, a quaternary healthcare center of excellence under Burjeel Holdings.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220914006072/en/
The medical team that performed the kidney transplant at Burjeel Medical City (Photo: AETOSWire)
The patient had end-stage renal failure and was undergoing dialysis since March 2022. “The patient was physically fit and did not have other contraindications. The surgery was conducted after both the patient and the donor (the patient’s nephew) underwent thorough evaluations and were deemed fit for the procedure,” said Dr. Rehan Saif, Director - Transplant Surgery, BMC.
Dr. Venkat S Vellanki, Consultant Nephrologist, BMC, who was also part of the medical team, said, “Very few institutions can offer 360-degree, 24x7 care for kidney patients with complex medical requirements under one roof. We have a multidisciplinary team backed by cutting-edge technology to facilitate kidney transplantation service. BMC can efficiently meet kidney patients’ diverse and personalized needs.”
The donor surgery was performed using the latest 3D laparoscopic technology, a minimally invasive method meant to improve donor safety. After the donor surgery was completed in four hours, the back bench preparation of the graft took 45 minutes. The recipient surgery was completed in four hours. According to the medical team, both the patient and the donor are recovering well.
Naser Al Riyami, Chief Operating Officer, BMC, said, “Our longstanding experience in healthcare has taught us valuable lessons in meeting the needs and requirements of people from around the world. We take our responsibility of providing patients with exceptional service and medical care seriously. We hope that such procedures will attract more medical tourists to the UAE. In the future, we aim to set a benchmark in the area of kidney transplants.”
About Burjeel Medical City
Burjeel Medical City (BMC) is a 400-bed multi-specialty hospital and quaternary care center located in Abu Dhabi, UAE. BMC offers high-quality specialized treatment and emergency care in over 39 adult and pediatric specialties, aided by state-of-the-art medical technology and an international team of experts certified by top global medical boards.
Find more information at https://www.burjeelmedicalcity.com/
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220914006072/en/
Contact information
M Unnikrishnan
krish@burjeelholdings.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hydnum Steel Secures 500 MW of Electrical Power, a Key Step Forward in the Construction of Its Clean Steel Plant in Spain27.2.2026 01:00:00 EET | Press release
Hydnum Steel has taken a decisive step towards constructing Spain’s first clean steel plant after being granted access to the electricity grid at the Brazatortas node in the province of Ciudad Real. The company has been granted an electricity capacity of 500 MW, as published in the Official State Gazette, which should be enough to guarantee supply to its electric arc furnace. This concession marks a significant milestone for a pioneering project in the Iberian Peninsula. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260225309290/en/ Image recreating the steel plant that Hydnum Steel will build in Puertollano, Spain Hydnum Steel is consolidating its position as a reliable supplier of clean European steel. The fully digitally integrated plant will produce hot-rolled steel coils efficiently and sustainably, with benefits for the environment and the economy. Hydnum Steel will deliver a solution for steel-consuming industries th
1089 Inc. Partners with Price Forbes and Oka-Lloyd's Syndicate 1922 to Launch Market-Defining First: Carbon Asset Insurance Framework for Transportation and Energy Sectors27.2.2026 00:01:00 EET | Press release
1089 Inc., in collaboration with Price Forbes and Oka, The Carbon Insurance Company, announce launch of an insured carbon asset designed to bring institutional safeguards, disciplined financial architecture, and verifiable data integrity to carbon markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226012782/en/ 1089 Inc. is Advancing Carbon™, focused on evolving global carbon markets and decarbonizing the highest-emitting sectors on the planet: Transportation and Energy. The framework provides defined risk coverage for 1089’s CX89 Advanced Fuels Carbon Assets, underwritten by Lloyd’s Syndicate 1922 and placed with the support of Price Forbes and Oka. The program introduces institutional-grade protection designed to prevent performance losses resulting from credit degradation between wrapping and minting. Luke Hanley, Founder and CEO of 1089 Inc., shared the framework’s core thesis: “The future of carbon markets is no
Sun Nuclear QADS 2026 Event Combines Clinical Insight and New Innovations for Advancing Radiation Therapy QA27.2.2026 00:00:00 EET | Press release
Sun Nuclear, a Mirion Medical company, today opened the QA & Dosimetry Symposium (QADS), taking place over the next two days in Rome, Italy. The 15th installment brings together more than 230 clinical physicists and radiation medicine professionals from nearly 40 countries. Participants from diverse clinical environments will earn continuing education credits while sharing practical insights, emerging approaches, and real-world experiences shaping the future of quality and patient safety in cancer care. Building on its legacy as a peer-driven forum with practical applications, QADS 2026 features sessions delivered by 24 speakers spanning: Future Directions in Machine and Patient QA and In-vivo Dosimetry Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) QA Safety and Guideline-driven Tool Selection Emerging Technologies, including Theranostics, AI and Automation Reinforcing its role as a launch point for clinically grounded innovation, QADS 2026 will serve a
Lattice to Highlight Low Power, Edge-Ready Programmable Solutions at embedded world 202626.2.2026 23:00:00 EET | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced its exhibition plan for embedded world 2026, where it will demonstrate how its low power, small form factor FPGA innovations help engineers accelerate intelligent, scalable designs from cloud to sensor. At the event, Lattice will participate in expert panel discussions, lead conference sessions, and host an interactive booth experience filled with real-world solutions for the Automotive, Industrial, and Security markets from Lattice and its innovation partners. Who: Lattice Semiconductor What / When: Lattice Booth and Demo Showcase: March 10 – 12, Hall 4, Booth #528 Expert Panel featuring Lattice Chief Strategy and Marketing Officer Esam Elashmawi March 10 at 1:30 p.m. GMT+1, Hall 3, Booth #611 Conference Sessions March 10 at 5 p.m. GMT+1 Safety & Security: “Trusted Resilience Edge – Unified FPGA-TPM for Post-Quantum Cryptography RED & Cyber Resilience Act” March 11 at 10:30 a.m. GMT+1 IoT & Connec
Loomis Sayles Euro Credit Team Celebrates Five-Year Milestones26.2.2026 18:00:00 EET | Press release
Loomis, Sayles & Company, the century-old investment manager with €363.8 billion in assets under management, celebrates the five-year anniversaries of its Loomis Sayles Euro Credit and Loomis Sayles Euro High Yield strategies. The Loomis Sayles Euro Credit Team, led by Co-Heads and Portfolio Managers Rik den Hartog and Pim van Mourik Broekman, manages €3.5 billion in assets across three strategies. Backed by Loomis Sayles’ industry-leading technology infrastructure and focused investment culture, the Euro Credit team seeks to generate consistent excess return versus the benchmark. The team believes this can be accomplished by using an active, conservative alpha investment process that aims to capitalize on inefficiencies in the euro credit market. Loomis Sayles Euro Credit invests primarily in investment grade, euro-denominated corporate bonds while Loomis Sayles Euro High Yield invests primarily in the BB segment of the euro-denominated high yield corporate bond market. The team’s Loo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom